You are here: Home » News-CM » Companies » Results
Business Standard

Jagsonpal Pharmaceuticals standalone net profit declines 59.00% in the March 2017 quarter

Capital Market 

Sales decline 24.56% to Rs 29.36 crore

Net profit of declined 59.00% to Rs 0.82 crore in the quarter ended March 2017 as against Rs 2.00 crore during the previous quarter ended March 2016. Sales declined 24.56% to Rs 29.36 crore in the quarter ended March 2017 as against Rs 38.92 crore during the previous quarter ended March 2016.

For the full year,net profit rose 264.92% to Rs 11.86 crore in the year ended March 2017 as against Rs 3.25 crore during the previous year ended March 2016. Sales rose 0.26% to Rs 143.87 crore in the year ended March 2017 as against Rs 143.49 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales29.3638.92 -25 143.87143.49 0 OPM %1.6312.67 -4.278.64 - PBDT0.333.29 -90 3.587.16 -50 PBT0.102.36 -96 1.594.07 -61 NP0.822.00 -59 11.863.25 265

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU